Please enter your username and password below, if you are not yet a member of Oncology Central remember you can register for free.
Or register via social media
Already have an account? Login here
Categories // Spotlights // Spotlight on tumor mutation burden
Tumor mutational burden (TMB) is promising as a predictive biomarker and could potentially lead the way for immuno-oncology to enter an era of precision medicine. In this Spotlight we will explore the use of TMB, challenges and future directions.
To kick-start this special focus, we want to hear your thoughts on the topic – click here to complete our short survey on TMB and be the first to receive our informative infographic collated from the survey results.
Updated 14 January, 2019